PMC:7696151 / 14055-14392 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"411","span":{"begin":126,"end":134},"obj":"Species"},{"id":"412","span":{"begin":199,"end":207},"obj":"Species"},{"id":"413","span":{"begin":292,"end":300},"obj":"Species"}],"attributes":[{"id":"A411","pred":"tao:has_database_id","subj":"411","obj":"Tax:9606"},{"id":"A412","pred":"tao:has_database_id","subj":"412","obj":"Tax:9606"},{"id":"A413","pred":"tao:has_database_id","subj":"413","obj":"Tax:9606"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"l the end of the 144th week. After 114 weeks, viral load was reduced by 1.6 Log10 copies/mL under baseline (p \u003c 0.001), eight patients (47%) had an unnoticeable viral load (\u003c 400 copies/mL), and two patients (12%) had a measurable viral load, but resistance mutations were not detected. Four patients (24%) had both detectable viral load"}

{"project":"LitCovid-sentences","denotations":[{"id":"T111","span":{"begin":29,"end":286},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"l the end of the 144th week. After 114 weeks, viral load was reduced by 1.6 Log10 copies/mL under baseline (p \u003c 0.001), eight patients (47%) had an unnoticeable viral load (\u003c 400 copies/mL), and two patients (12%) had a measurable viral load, but resistance mutations were not detected. Four patients (24%) had both detectable viral load"}